Xue-yong Zhu

Wuhan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Author Correction: Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy.

Author Correction: Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy.

Journal: Nature communications
Published: May 25, 2023

Ca2+-Dependent NOX5 (NADPH Oxidase 5) Exaggerates Cardiac Hypertrophy Through Reactive Oxygen Species Production.

Ca2+-Dependent NOX5 (NADPH Oxidase 5) Exaggerates Cardiac Hypertrophy Through Reactive Oxygen Species Production.

Journal: Hypertension (Dallas, Tex. : 1979)
Published: July 21, 2020

Integrated Omics Reveals Tollip as an Regulator and Therapeutic Target for Hepatic Ischemia-Reperfusion Injury in Mice.

Integrated Omics Reveals Tollip as an Regulator and Therapeutic Target for Hepatic Ischemia-Reperfusion Injury in Mice.

Journal: Hepatology (Baltimore, Md.)
Published: March 19, 2019

Corrigendum to "Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1" [J Hepatol 69 (2018) 1110-1122].

Corrigendum to "Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1" [J Hepatol 69 (2018) 1110-1122].

Journal: Journal of hepatology
Published: January 09, 2019

F-box/WD Repeat-Containing Protein 5 Mediates the Ubiquitination of Apoptosis Signal-Regulating Kinase 1 and Exacerbates Nonalcoholic Steatohepatitis in Mice.

F-box/WD Repeat-Containing Protein 5 Mediates the Ubiquitination of Apoptosis Signal-Regulating Kinase 1 and Exacerbates Nonalcoholic Steatohepatitis in Mice.

Journal: Hepatology (Baltimore, Md.)
Published: October 29, 2018

Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.

Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.

Journal: Journal of the American Heart Association
Published: June 28, 2018

Tollip Negatively Regulates Vascular Smooth Muscle Cell-Mediated Neointima Formation by Suppressing Akt-Dependent Signaling.

Tollip Negatively Regulates Vascular Smooth Muscle Cell-Mediated Neointima Formation by Suppressing Akt-Dependent Signaling.

Journal: Journal of the American Heart Association
Published: June 12, 2018

Wang et al. reply.

Wang et al. reply.

Journal: Nature medicine
Published: June 06, 2018

Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1.

Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1.

Journal: Journal of hepatology
Published: November 07, 2017

Corrigendum: Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates.

Corrigendum: Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates.

Journal: Nature medicine
Published: October 07, 2017

The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis.

The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis.

Journal: Nature medicine
Published: September 26, 2017

Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6.

Ubiquitin-Specific Peptidase 10 (USP10) Inhibits Hepatic Steatosis, Insulin Resistance, and Inflammation Through Sirt6.

Journal: Hepatology (Baltimore, Md.)
Published: September 20, 2017
Showing 1-12 of 31

Last Updated: 09/26/2026